Total Funding
78
65
Total FundingPost-IPO Equity raised
Growth Score
-17 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
40938
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
- Peter Thompson: Co-Founder and DirectorPast Role: Terremoto Biosciences, CEO and Co-Founder
- Leiv Lea: CFO
About the Company
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
